Characterization of arbutamine: A novel catecholamine stress agent for diagnosis of coronary artery disease
- 1 May 1994
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 32 (1) , 19-28
- https://doi.org/10.1002/ddr.430320105
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Effects of dobutamine and arbutamine on regional myocardial function in a porcine model of myocardial ischemiaJournal of the American College of Cardiology, 1994
- Dobutamine stress echocardiography for detection and assessment of coronary artery diseaseJournal of the American College of Cardiology, 1992
- Dobutamine stress echocardiography: Correlation with coronary lesion severity as determined by quantitative angiographyJournal of the American College of Cardiology, 1992
- Accuracy and limitations of exercise echocardiography in a routine clinical settingJournal of the American College of Cardiology, 1992
- Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: Comparison with positron emission tomographyJournal of the American College of Cardiology, 1990
- The effects of dopamine and dobutamine on regional function in the presence of rigid coronary stenoses and subcritical impairments of reactive hyperemiaAmerican Heart Journal, 1988
- Influence of dobutamine on hemodynamics and coronary blood flow in patients with and without coronary artery diseaseThe American Journal of Cardiology, 1976
- Effects of Dobutamine on Left Ventricular Performance, Coronary Dynamics, and Distribution of Cardiac Output in Conscious DogsJournal of Clinical Investigation, 1974
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- ELECTROCARDIOGRAPHIC CHANGES DURING ATTACKS OF ANGINA PECTORISThe Lancet Healthy Longevity, 1928